These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15291686)

  • 1. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?
    Kleindienst N; Greil W
    J Clin Psychiatry; 2004 Jul; 65(7):966-74. PubMed ID: 15291686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.
    Hartong EG; Moleman P; Hoogduin CA; Broekman TG; Nolen WA;
    J Clin Psychiatry; 2003 Feb; 64(2):144-51. PubMed ID: 12633122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
    Baethge C; Baldessarini RJ; Mathiske-Schmidt K; Hennen J; Berghöfer A; Müller-Oerlinghausen B; Bschor T; Adli M; Bauer M
    J Clin Psychiatry; 2005 Feb; 66(2):174-82. PubMed ID: 15705002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonadherence with mood stabilizers: prevalence and predictors.
    Scott J; Pope M
    J Clin Psychiatry; 2002 May; 63(5):384-90. PubMed ID: 12019661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concepts in the treatment of bipolar disorder.
    Greil W; Kleindienst N
    Acta Psychiatr Scand Suppl; 2003; (418):41-6. PubMed ID: 12956813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.
    Shukla S; Cook BL; Miller MG
    J Affect Disord; 1985 Nov; 9(3):219-22. PubMed ID: 2867109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar disorder.
    Mitchell PB; Parker GB
    Med J Aust; 1991 Oct; 155(7):488-93. PubMed ID: 1921822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of relapse in bipolar disorder.
    Silverstone T; Romans S
    N Z Med J; 1995 Oct; 108(1009):397-8. PubMed ID: 7478331
    [No Abstract]   [Full Text] [Related]  

  • 13. The increasing use of anticonvulsants in prophylactic treatment of bipolar disorder.
    Yang YY; Deng HC; Wang BH
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):429-31. PubMed ID: 9766693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosensory symptoms in bipolar disorder.
    Ali SO; Denicoff KD; Ketter TA; Smith-Jackson EE; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):223-31. PubMed ID: 9359118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J; Kravitz HM
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.
    Kleindienst N; Greil W
    Psychol Med; 2002 Apr; 32(3):493-501. PubMed ID: 11989994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C; König B; Amann BL
    J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.